- Home
- ATLX vs STRO Comparison
ATLX vs STRO Comparison
Compare ATLX & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATLX
- STRO
- Stock Information
- Founded
- ATLX 2011
- STRO 2003
- Country
- ATLX Brazil
- STRO United States
- Employees
- ATLX N/A
- STRO N/A
- Industry
- ATLX Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ATLX Industrials
- STRO Health Care
- Exchange
- ATLX Nasdaq
- STRO Nasdaq
- Market Cap
- ATLX 111.7M
- STRO 94.9M
- IPO Year
- ATLX N/A
- STRO 2018
- Fundamental
- Price
- ATLX $4.51
- STRO $0.80
- Analyst Decision
- ATLX
- STRO Hold
- Analyst Count
- ATLX 0
- STRO 7
- Target Price
- ATLX N/A
- STRO $1.97
- AVG Volume (30 Days)
- ATLX 1.0M
- STRO 1.7M
- Earning Date
- ATLX 11-04-2025
- STRO 11-06-2025
- Dividend Yield
- ATLX N/A
- STRO N/A
- EPS Growth
- ATLX N/A
- STRO N/A
- EPS
- ATLX N/A
- STRO N/A
- Revenue
- ATLX $350,003.00
- STRO $105,646,000.00
- Revenue This Year
- ATLX $22,084.55
- STRO $65.48
- Revenue Next Year
- ATLX N/A
- STRO N/A
- P/E Ratio
- ATLX N/A
- STRO N/A
- Revenue Growth
- ATLX N/A
- STRO N/A
- 52 Week Low
- ATLX $3.54
- STRO $0.52
- 52 Week High
- ATLX $9.13
- STRO $4.60
- Technical
- Relative Strength Index (RSI)
- ATLX 39.06
- STRO 37.50
- Support Level
- ATLX $4.36
- STRO $1.01
- Resistance Level
- ATLX $4.64
- STRO $1.20
- Average True Range (ATR)
- ATLX 0.50
- STRO 0.12
- MACD
- ATLX -0.16
- STRO -0.03
- Stochastic Oscillator
- ATLX 15.02
- STRO 3.36
About ATLX Atlas Lithium Corporation
Atlas Lithium Corp is a mineral exploration and development company with lithium projects and exploration properties in other critical and battery minerals, including nickel, rare earth, graphite, and titanium, to power the increased demand for electrification. Its focus is on developing its hard-rock lithium project Minas Gerais Lithium Project located in Minas Gerais State in Brazil. The company intends to produce and sell lithium concentrate, a key ingredient for the battery supply chain. It intends to mine and then process its lithium-containing ore to produce lithium concentrate (also known as spodumene concentrate), a key ingredient for the battery supply chain.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.